ライフサイエンスコーパス: patient presenting with

1 ped two standardised patient cases: first, a patient presenting with 2-3 weeks of pulmonary tuberculo

2 Ten healthy adult patients presenting with 21 Miller Class I gingival rece

3 Here we describe a patient presenting with a complete lack of B lymphocytes

4 onsidered in the differential diagnosis of a patient presenting with a gradually progressive orbital

5 Case Report: A middle-aged female patient presenting with a history of multiple chronic ne

6 Furthermore, in a patient presenting with a severe form of primary microce

7 cilli (GNB) bloodstream infections (BSIs) in patients presenting with a beta-lactam (BL) allergy is o

8 ked, multicenter clinical trial enrolled 128 patients presenting with a clinical diagnosis of acute v

9 In patients presenting with a clinically isolated syndrome,

10 ly, these findings suggest that mesothelioma patients presenting with a family history of cancer shou

11 We performed a retrospective study of 189 patients presenting with a first SCAD episode.

12 Patients presenting with a first symptomatic, proximal D

13 raniectomy, and improve clinical outcomes in patients presenting with a large hemispheric infarction.

14 ted on the use of the following protocol for patients presenting with a Los Angeles Motor Scale score

15 sequencing and autozygome-based screening of patients presenting with a peculiar, recessive form of c

16 Patients presenting with a penetrating chest wound and a

17 When screening uncomplicated patients presenting with a productive cough for pulmonar

18 9.7%; P for trend=0.021), although solely in patients presenting with a shockable initial rhythm (N=2

19 Young patients presenting with a solitary meningioma or schwan

20 From 9 October 2012 to 21 March 2013, patients presenting with a sore throat meeting criteria

21 o investigate predictors for mortality among patients presenting with ABAD and to create a predictive

22 The typical clinical scenario is a young patient presenting with abdominal pain, chronic diarrhoe

23 us complication must always be remembered in patients presenting with abdominal pain after stent inse

24 Data from 6,855 patients presenting with ACS in whom PCI was performed w

25 emic immune responses in peritoneal dialysis patients presenting with acute bacterial peritonitis and

26 ould be considered and diagnosed promptly in patients presenting with acute chest or back pain and hi

27 presents an attractive alternative to triage patients presenting with acute chest pain.

28 c features of early stent thrombosis (ST) in patients presenting with acute coronary syndrome (ACS).

29 after percutaneous coronary intervention in patients presenting with acute coronary syndrome is inde

30 cute Coronary Syndrome (APTITUDE-ACS) study, patients presenting with acute coronary syndrome or for

31 after percutaneous coronary intervention in patients presenting with acute coronary syndrome.

32 n and patient Outcomes (PLATO) study, 18 624 patients presenting with acute coronary syndromes random

33 demic for Lyme and other tickborne diseases, patients presenting with acute febrile illness with myal

34 to >35% and >/=50% after 90-day follow-up in patients presenting with acute MI and severe LV dysfunct

35 own as S100A9) is elevated in platelets from patients presenting with acute myocardial infarction (MI

36 tudy population and for a subset of Medicare patients presenting with acute myocardial infarction.

37 of perceived stress in young and middle-aged patients presenting with acute myocardial infarction.

38 antly higher 30-day in-hospital mortality in patients presenting with acute myocardial infarction.

39 s with elevated serum triglyceride levels to patients presenting with acute myocardial infarction.

40 o address these early and late aspects, 2291 patients presenting with acute or stable coronary diseas

41 h at a national level clinical outcomes from patients presenting with acute para-esophageal hernia (P

42 Patients presenting with acute respiratory illness were

43 In this large hospital-based cohort of patients presenting with acute stroke, acid-suppressive

44 otential diagnosis should be kept in mind in patients presenting with acute upper abdomen pain and di

45 This study suggests that management of patients presenting with adhesive-SBO by a primary medic

46 te diagnosis results in approximately 30% of patients presenting with advanced, irreversible organ in

47 identify a novel PSTPIP1-R405C mutation in a patient presenting with aggressive pyoderma gangrenosum.

48 ticenter, prospective cohort study enrolling patients presenting with AHF requiring intravenous diure

49 FAS ligand deficiency should be screened in patients presenting with ALPS features but lacking the u

50 y of appendicitis must be entertained in any patient presenting with an acute abdomen.

51 the case of a 66-year-old anal cancer female patient presenting with an asymptomatic sub-hepatic mass

52 nd parasites and PBMCs were isolated from 35 patients presenting with an acute case of uncomplicated

53 For patients presenting with an acute ST-segment-elevation m

54 ional diagnoses that should be considered in patients presenting with an acute TMA, especially in pat

55 Over 5 years in patients presenting with an FCDE, early sc IFN beta-1a t

56 Patients presenting with an initial GCS of less than 8 o

57 antitative immunohistochemistry) with 4 of 9 patients presenting with an intermediate muscular dystro

58 Patients presenting with an isolated decline in FEV1 (FE

59 rospective review of a consecutive series of patients presenting with an rAAA before (1997-2006) and

60 This study aimed to analyze how quickly patients presenting with anaphylaxis were treated in eme

61 characteristics were compared with those of patients presenting with anti-FH Ab-associated aHUS.

62 Absent other causes, patients presenting with any 2 of the following meet the

63 meshift mutations identified in RAD21 in two patients presenting with atypical CdLS.

64 ity of performing RAD21 mutation analysis in patients presenting with atypical forms of CdLS.

65 Mutations of MAGEL2 have been reported in patients presenting with autism, and loss of MAGEL2 is a

66 onsisted of 132 age-, sex-, and race-matched patients presenting with benign dermatologic conditions.

67 One hundred P2Y12 inhibitor-naive patients presenting with biomarker-negative ACS and unde

68 could be used as a rapid screening assay in patients presenting with bleeding symptoms, and detects

69 e differential diagnosis of fumarate-treated patients presenting with brain lesions or seizures even

70 The improvement was primarily found in patients presenting with CAD in more vessels than the nu

71 uting factor in myocardial infarction and in patients presenting with cardiomyopathy.

72 presentative sample of adult Mexican Mestizo patients presenting with CD.

73 Differences in retention between patients presenting with CD4 counts just above versus ju

74 But up to 28 % of patients presenting with central retinal vein occlusion

75 itigating risk and treatment of HIV-positive patients presenting with CHD.

76 from a local database of patients to triage patients presenting with chest discomfort after PCI.

77 data from two risk-matched cohorts of 894 ED patients presenting with chest pain to assess the impact

78 e used to measure troponin concentrations in patients presenting with chest-pain symptoms and being i

79 aluation and tests used in the assessment of patients presenting with chronic diarrhea are reviewed,

80 ion in the routine genetic evaluation of all patients presenting with chronic progressive cerebellar

81 Between 2003 and 2011, 10 HIV-1-infected patients presenting with chronic pseudotumoral anogenita

82 of this uncommon syndrome in a 12 years old patient presenting with classical complaints of developm

83 ization were greater for PVI than for LEB in patients presenting with claudication (12.3+/-2.7% and 1

84 This classification restricts patients presenting with clinical criteria characteristi

85 Of 607 patients presenting with clinical stage II/III disease,

86 ntinel lymph node biopsy (SLNB) after NAC in patients presenting with clinically negative nodes has a

87 f more immunotherapy-responsive syndromes in patients presenting with cognitive and behavioral proble

88 helpful in the evaluation and management of patients presenting with colonic perforation, especially

89 ied loss-of-function mutations in NSUN3 in a patient presenting with combined mitochondrial respirato

90 rom biopsy material obtained from a diabetic patient presenting with complaints of headache and malai

91 tem can help improve the quality of care for patients presenting with complex cancers requiring subsp

92 particular C-P4H-I, should be considered in patients presenting with congenital connective tissue/my

93 stic assessment, and therapeutic approach to patients presenting with CP and RCM.

94 sequencing to identify SLC52A2 mutations in patients presenting with cranial neuropathies and sensor

95 ), and (4) wound healing and limb salvage in patients presenting with critical limb ischemia; seconda

96 Among patients presenting with critical lower extremity ischem

97 Not all patients presenting with CTEPH have a history of clinica

98 From 1,022 consecutive patients presenting with definite diagnoses of infective

99 line the clinical evaluation indicated for a patient presenting with demyelinating polyneuropathy and

100 led trial of acupuncture and counselling for patients presenting with depression, after having consul

101 (DEB) and everolimus-eluting stents (EES) in patients presenting with DES-ISR.

102 d in conjunction with fundoplication even in patients presenting with device erosion.

103 Zambia and compared these with isolates from patients presenting with diarrhoea in the same region.

104 ate antiplatelet strategy for the individual patient presenting with different clinical manifestation

105 thy is an important diagnosis to consider in patients presenting with distal leg muscle weakness.

106 diagnosis should be considered primarily in patients presenting with distal weakness (foot drop) in

107 However, most patients presenting with distant metastases, are not res

108 Among patients presenting with diverse neurological problems,

109 sk factors for CSF discordance and escape in patients presenting with diverse neurological problems.

110 ould be considered the optimal treatment for patients presenting with duodenal obstruction from SMA s

111 considered in the differential diagnosis of patients presenting with dyspnea, congestion, and a norm

112 national guidelines for the resuscitation of patients presenting with early septic shock.

113 are the most commonly assessed mutations in patients presenting with early-onset breast cancer, trip

114 domized controlled trial was conducted in 28 patients presenting with EGD.

115 the location and degree of FDG uptake in CS patients presenting with either advanced atrioventricula

116 ospectively analysed a cohort of consecutive patients presenting with embolic stroke at an academic h

117 immunity deserves consideration in pediatric patients presenting with encephalitis.

118 We excluded patients presenting with endocarditis.

119 er, in four EoE families, we have identified patients presenting with EoE-typical and corticosteroid-

120 Total sample included 246 patients presenting with ES (221 men; age: 65+/-9 years)

121 ormed to rule out acute coronary syndrome in patients presenting with exertional chest pain.

122 Here we report the case of a patient presenting with features of benign recurrent int

123 hese regions, dengue should be considered in patients presenting with fever and acute neurological ma

124 have a high index of suspicion when treating patients presenting with fever, headache, and confusion.

125 e age of 45 years (57% vs. 94%, P=0.03), and patients presenting with fewer than 100,000 EBOV copies

126 novirus (ADV) infection in four adult cancer patients presenting with focal pulmonary consolidation.

127 a reliable means for controlling seizures in patients presenting with focal seizures.

128 A chart review of all patients presenting with full-thickness MH from exposure

129 From 1988 to 2014, all patients presenting with GA 16 to 60 years of age were e

130 a neurosurgical intervention were similar in patients presenting with GCS scores of 3 to 8 and GCS sc

131 In this study, we studied 17 patients presenting with GP who were positive for anti-F

132 hageal varices were the commonest finding in patients presenting with haematemesis, increasing by 14

133 to 0.98) and each per cent point increase in patients presenting with haemorrhage (RR 0.98, 95% CI 0.

134 l genome sequences of 171 HIV-HBV coinfected patients, presenting with HBV viremia for at least one v

135 Hospitalized patients presenting with heart disease but not heart fai

136 ppears better than generally considered, but patients presenting with heart failure still have poor l

137 The virus was isolated from patients presenting with hemorrhagic manifestations and

138 Concurrent antibody screening of patients presenting with hepatitis symptoms documented p

139 Liver histology from 128 patients presenting with hepatocellular injury had more

140 NLPHL patients presenting with histopathologic variants have a

141 Patients presenting with HUS had a significantly shorten

142 concurrent illness might predispose certain patients presenting with hyperkalemia to a lower or high

143 such as improved blood pressure control in a patient presenting with hypertension and loss of medicat

144 Joubert Syndrome should be ruled out in all patients presenting with hypotonia, ataxia, nystagmus, b

145 Clinical characteristics of 8 patients presenting with in-the-bag intraocular lens dis

146 In high-risk patients presenting with increased creatinine more than

147 58) were reported as symptoms, and longer in patients presenting with indigestion (0.71, 0.56-0.89; p

148 high suspicion for the development of AEF in patients presenting with infective, neurological, gastro

149 by RT-PCR were collected from the first ten patients presenting with influenza-like illness each wee

150 Patients presenting with initial shock-refractory VF/VT

151 We studied a patient presenting with insidious impairment of basic vi

152 , including DES and drug-coated balloons, in patients presenting with ISR within bare-metal stents or

153 quire physicians to comprehensively evaluate patients presenting with kidney stones.

154 and to discuss the differential diagnosis in patients presenting with LETM.

155 It carries mutations in patients presenting with limb-girdle muscular dystrophy

156 Patient presenting with logopenic variant primary progre

157 A total of 335 patients presenting with MC activation syndrome, includi

158 nced stage at diagnosis, with 72.5% of obese patients presenting with metastatic disease versus 59.4%

159 vival of less than 10%, and more than 50% of patients presenting with metastatic disease.

160 abdomyosarcoma is over 70%, but only 30% for patients presenting with metastatic disease.

161 genic YARS2 variants should be considered in patients presenting with mitochondrial myopathy, charact

162 Participants were a consecutive sample of patients presenting with MMS for 35 weeks at each center

163 lasticity is not associated with age, but AD patients presenting with more altered LTP-like cortical

164 iles and was not explained by differences in patients presenting with multiple complications on the i

165 fied 2 gain-of-function somatic mutations in patients presenting with multiple paragangliomas or soma

166 tumor is critical for surgical treatment of patients presenting with neuroendocrine tumor (NET) with

167 In patients presenting with nfvPPA, presence of early sever

168 de surgery after neoadjuvant chemotherapy in patients presenting with node-positive breast cancer fro

169 In patients presenting with node-positive disease, clinical

170 nary calcification on outcomes after PCI for patients presenting with non-ST-segment elevation and ST

171 le of complete coronary revascularization in patients presenting with non-ST-segment elevation myocar

172 y was performed in a formal substudy of 6921 patients presenting with non-ST-segment-elevation acute

173 AIS patients with elevated cTn compared with patients presenting with non-ST-segment-elevation acute

174 In patients presenting with nonshockable cardiac rhythm aft

175 In patients presenting with normal ALT or INR, miR-122, HMG

176 cardial Ischaemia National Audit Project for patients presenting with NSTE-ACS to English or Welsh ho

177 te of death or MI was significant only among patients presenting with NSTEMI (HR: 0.67; CI: 0.59 to 0

178 We reviewed the management of patients presenting with obscure gastrointestinal bleedi

179 Bilateral findings were found in 7 of 10 patients presenting with ocular lesions, the most common

180 The notes of all patients presenting with ocular trauma in the specified

181 inical practices that include screening of a patient presenting with one disorder for the other.

182 pared with the observed standard of care for patients presenting with opioid use disorder to Californ

183 lcer; and specific disability prevention for patients presenting with osteomyelitis, oedema, or multi

184 describe evidence of somatic mosaicism in a patient presenting with over 130 CCM lesions localized t

185 This study included HIV-infected patients presenting with P. marneffei (n = 719) and Cryp

186 CASE PRESENTATION: A 30 year - old male patient presenting with pain to the upper abdomen due to

187 Of patients presenting with pain or peripheral nervous syst

188 In patients presenting with painful proptosis and vision lo

189 If a patient presenting with PAMM is young and healthy withou

190 aining clinical suspicion for botulism among patients presenting with paralytic illness to facilitate

191 Patients presenting with parkinsonian syndromes share ma

192 Patients presenting with parkinsonism dystonia or a neur

193 tive analysis of the tomographic findings in patients presenting with PEDs may allow ophthalmologists

194 A total of 50 consecutive patients presenting with perianal fistulous disease fulf

195 diagnosis and treatment plan can be made for patients presenting with periorbital and ocular surface

196 blinded review of skin biopsy specimens from patients presenting with plaques.

197 ese viruses, we aimed to isolate them from a patient presenting with pneumonia.

198 o analyze the outcome of hepatoblastoma (HB) patients presenting with post treatment extent of diseas

199 In additional patients presenting with PPGL and polycythemia, no furth

200 de a framework for the clinician assessing a patient presenting with predominantly LMN features.

201 In the subgroup of patients presenting with preserved vessel flow, rates of

202 we evaluate the management of a one-time new patient presenting with presumptive TB, which may not re

203 esent an unusual case of a kidney transplant patient presenting with progressive neurological deterio

204 We report a patient presenting with prolonged mild headaches and acu

205 s were similar in terms of the proportion of patients presenting with prolonged air leakage (7.8% in

206 s were similar in terms of the proportion of patients presenting with prolonged air leakage (7.8% in

207 Patients presenting with proven/probable LRTI had a medi

208 INTERPRETATION: Patients presenting with pure autonomic failure are at h

209 d sensory neuropathies, including four young patients presenting with pure motor axonal neuropathy.

210 considered in the differential diagnosis of patients presenting with RACU, and a multidisciplinary a

211 reciation of the variable natural history of patients presenting with radiologically evident Balo les

212 Patients presenting with rapid onset of cardiomyopathy,

213 n-PV triggers were found and targeted in all patients presenting with recurrent arrhythmia after >/=2

214 A human cardiac sample was obtained from a patient presenting with reduced left ventricular (LV) fu

215 Patients presenting with 'refractory GERD' in fact repre

216 Patients presenting with RVO to Creteil University Eye C

217 Among patients presenting with SAB and no signs of pocket infe

218 ify clinical predictors of CIED infection in patients presenting with SAB and no signs of pocket infe

219 edic surgery and 0.51 (95% CI, 0.28-0.95) in patients presenting with sepsis.

220 eeded and may have important implications in patients presenting with septic shock or stroke.

221 istress syndrome, with possible exception of patients presenting with septic shock.

222 We report a case of a HLA-B27 negative patient presenting with severe, bilateral, idiopathic ac

223 ted to improve early outcomes, especially in patients presenting with severe disease and requiring in

224 ion of pulse co-oximetry-based hemoglobin in patients presenting with severe gastrointestinal bleeds

225 s associated with a decreased probability of patients presenting with severe PAD and resolution of me

226 Consecutive patients presenting with severe sepsis or septic shock f

227 thin the aortic wall, should be suspected in patients presenting with severe thoracic pain and hypert

228 Twenty-nine consecutive patients presenting with severe uveitis that required an

229 luster of reports in the literature describe patients presenting with sinus bradycardia in associatio

230 patients met two or more SIRS criteria, and patients presenting with SIRS had higher in-hospital mor

231 Patients presenting with skin cancer on the trunk were c

232 systemic involvement at presentation, and no patient presenting with solely orbital GPA developed lat

233 6-20 years, among whom approximately 1 in 13 patients presenting with sore throat has mononucleosis).

234 In adolescent and adult patients presenting with sore throat, the presence of po

235 Patients presenting with spontaneous or drug-induced Bru

236 Patients presenting with spontaneous or drug-induced Bru

237 Patients presenting with spontaneous or drug-induced Bru

238 The diagnosis should be considered in patients presenting with sporadic episodes of haematuria

239 o compare the immunization status of grafted patients presenting with SSD following ATG induction tre

240 Two hundred thirty-one patients presenting with ST underwent OCT imaging; 14 (6

241 Consecutive patients presenting with ST were prospectively enrolled

242 to compare radial and femoral approaches in patients presenting with ST-segment elevation myocardial

243 eased, more TRIs were performed in women, in patients presenting with ST-segment elevation myocardial

244 s as the revascularisation strategy for many patients presenting with ST-segment elevation myocardial

245 In a follow-up study, 181 patients presenting with ST-segment-elevation myocardial

246 Patients presenting with ST-segment-elevation myocardial

247 hievement of quality performance measures in patients presenting with ST-segment-elevation myocardial

248 It is estimated that up to two thirds of patients presenting with ST-segment-elevation myocardial

249 a shortened version of the SAQ (SAQ-7) among patients presenting with stable CAD, undergoing percutan

250 We randomized 360 patients presenting with stable or unstable angina (28%

251 Patients presenting with stage IIIE-IV follicular lympho

252 ntable electronic device (CIED) infection in patients presenting with Staphylococcus aureus bacteremi

253 A prior history of CABG in patients presenting with STEMI and undergoing PPCI does

254 d study in Oxfordshire, UK, we recruited all patients presenting with stroke between April 1, 2002, a

255 tinguish ischemic from hemorrhagic stroke in patients presenting with stroke-like symptoms is essenti

256 MATERIAL/Sixty patients presenting with suprahyoid neck masses underwen

257 AMI with a negative predictive value >99% in patients presenting with suspected acute coronary syndro

258 ntation in 2 cohorts: a diagnostic cohort of patients presenting with suspected AMI and a prognostic

259 Not all patients presenting with suspected diverticulitis were e

260 center diagnostic study enrolling unselected patients presenting with suspected non-ST-segment elevat

261 , and included studies that provided data on patients presenting with suspected TIA who underwent MR

262 idance for the use of anticoagulant drugs in patients presenting with SVT, including symptomatic as w

263 may be a more thorough diagnostic work-up in patients presenting with SVT.

264 MATERIAL/We included consecutive patients presenting with symptomatic and sonographically

265 This study included patients presenting with symptomatic exudative retinal p

266 Dex+AA in the treatment of AL amyloidosis in patients presenting with symptomatic heart failure is as

267 Val) revealed by whole-exome sequencing in a patient presenting with symptoms of long-QT syndrome as

268 nd manage comorbid anxiety and depression in patients presenting with symptoms due to OA, with those

269 immunosuppression or as diagnostic tests in patients presenting with symptoms such as fever during n

270 sitive and 4 high-sensitivity cTn assays) in patients presenting with symptoms suggestive of acute my

271 , multicenter, randomized trial, we enrolled patients presenting with symptoms suggestive of an ACS a

272 A total of 3155 patients presenting with symptoms suggestive of cardiac

273 The final diagnosis was adjudicated in patients presenting with symptoms suggestive of myocardi

274 imaging (MPI) for intermediate- to high-risk patients presenting with syncope but not for low-risk pa

275 At last follow-up, none of the 5 patients presenting with T3bN0M0, nor the patient with T

276 gest careful evaluation and follow-up of all patients presenting with the sudden onset of cherry hema

277 an estimate of the prevalence of smoking in patients presenting with their first episode of psychosi

278 The prevalence of smoking in patients presenting with their first episode of psychosi

279 Tortuosity was common in patients presenting with their first SCAD event (78% ver

280 Patients presenting with their first STEMI and early QW

281 2, p<0.0001), with greatest benefit noted in patients presenting with TIA or minor stroke (at 0-2 wee

282 Patients presenting with tinnitus commonly have neuropsy

283 Consecutive patients presenting with treatment-naive active CSC unde

284 ue-stage FMF was almost identical to that of patients presenting with tumors (10-year OS, 25% vs 27%)

285 Ten healthy adult patients presenting with twenty-one Millers Class I rece

286 ng for CSF1R mutations is essential in adult patients presenting with undefined CNS vasculitis or a l

287 Serum chymase levels were measured in patients presenting with undifferentiated fever to hospi

288 Three patients presenting with unilateral cloudy vitelliform s

289 The proportion of patients presenting with unstable coronary artery diseas

290 rst diagnosis of RSV infection was lowest in patients presenting with URTI (31 of 197 [16%]).

291 A total of 853 patients presenting with uveitis were identified.

292 acy in a paediatric cohort of 30 undiagnosed patients presenting with variable neurometabolic phenoty

293 In patients presenting with varying severities of influenza

294 ashi," was obtained from a blood sample of a patient presenting with verruga peruana in the Ancash re

295 ia care (MAC) and general anesthesia (GA) in patients presenting with vertebrobasilar occlusion strok

296 beds, particularly in asymptomatic males, in patients presenting with visceral artery FMD.

297 ion as a first-line treatment in postinfarct patients presenting with VT might be a reasonable option

298 Both mean LV SUV and Max SUV in CS patients presenting with VT were significantly higher co

299 In patients presenting with VTE and with a significant blee

300 ferential diagnoses need to be considered in patients presenting with wheals and/or angioedema.